ReviewJournal of cancer survivorship : research and practice2026
Adolescent and young adult cancer survivor experiences of financial toxicity: a scoping review.
Review in Journal of cancer survivorship : research and practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdolescent and young adult (AYA) cancer survivors (ages 15-39 at diagnosis) experience challenges that heighten their risk of financial toxicity (i.e., the material, psychological, and behavioral burden of cancer-related costs). This scoping review characterizes the extent, range, and limitations of the literature on financial toxicity among AYA cancer survivors to inform future research and intervention design.
methodsFollowing standardized scoping review methodology, we systematically searched six databases for studies addressing financial toxicity or related constructs among AYAs within the past 10 years. Eligible studies included quantitative, qualitative, and mixed-methods research without geographic restriction. Of 1722 records identified, 1362 underwent title and abstract screening and 118 underwent full-text review. Two reviewers independently screened studies, and study data were extracted and synthesized.
resultsEighty studies met inclusion criteria. Most (n = 74, 92%) were cross-sectional, six (8%) were longitudinal. Half (n = 40, 50%) were quantitative observational analyses, and 41 (51%) included multiple cancer types. Financial toxicity was measured as an outcome in 63 studies (79%) and an exposure in 17 (21%). Prevalence of financial toxicity ranged from 15.5% to 89.5% (median 55%, IQR 38.2-67.1). Considerable heterogeneity was observed in measurement approaches; the Comprehensive Score for Financial Toxicity (COST) measure was used in 22 studies.
conclusionsStandardized measurement, longitudinal designs, and multilevel interventions are needed to mitigate burden and advance health equity. IMPLICATIONS FOR CANCER SURVIVORS: Financial toxicity is a pervasive concern for AYA cancer survivors globally. Through synthesizing the existing evidence on financial toxicity among AYA cancer survivors, this review identifies key gaps and guides future research and intervention development.
Indexed as
Identifiers
41770511What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.